๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma

โœ Scribed by Dr Jeffrey C. Allen; Gerald Rosen


Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
434 KB
Volume
3
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Renal function following combination che
โœ Arndt, Carola; Morgenstern, Bruce; Hawkins, Douglas; Wilson, David; Liedtke, Rob ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 104 KB ๐Ÿ‘ 1 views

## Background: Ifosfamide and cisplatin are active agents that are currently used in the treatment of osteosarcoma. nephrotoxicity has been reported following their use in combination and alone. this study evaluates renal function in children and adolescents (median age 16 years) at least 3 months

Transient neurologic dysfunction followi
โœ Roy L. Martino; Al B. Benson III; James A. Merritt; Jeffrey J. Brown; John R. Le ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 299 KB

Two patients, aged 24 and 19 years, who had undifferentiated lymphoma, developed the acute onset of focal neurologic deficits 10 days after treatment with moderate-dose methotrexate (2.76 g/m2 by 42-hour intravenous infusion) and 12.5 mg of intrathecal methotrexate. Prior chemotherapy also included

Testicular dysfunction after cyclophosph
โœ B. S. Charak; Rahul Gupta; Pranoti Mandrekar; Nandini A. Sheth; Shripad D. Banav ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 370 KB ๐Ÿ‘ 2 views

Gonadal functions were evaluated in 92 male patients after treatment for advanced Hodgkin's disease. The patients received six to ten cycles of cyclophosphamide, vincristine, procarbazine, and prednisolone (COPP) chemotherapy. All patients were in remission and were followed for 1 to 17 years (media

Osteogenic sarcoma of the extremity with
โœ Gaetano Bacci; Mario Mercuri; Antonio Briccoli; Stefano Ferrari; Franco Bertoni; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 2 views

## Background: In the past 20 years, it has been demonstrated that the combination of surgery and chemotherapy improves the prognosis for patients with osteosarcoma of the extremity without detectable metastases at presentation. by contrast, the efficacy of chemotherapy coupled with aggressive surg